Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome (Q33995610)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome |
scientific article |
Statements
1 reference
Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndrome (English)
1 reference
Hagop Kantarjian
1 reference
Jorge Cortes
1 reference
Tapan Kadia
1 reference
Susan O'Brien
1 reference
Farhad Ravandi
1 reference
Elias Jabbour
1 reference
Gautam Borthakur
1 reference
Guillermo Garcia-Manero
1 reference
Mark Brandt
1 reference
Hady Ghanem
1 reference
A Megan Cornelison
1 reference
19 August 2013
1 reference
1 reference
Identifiers
1 reference